1. Home
  2. FBIOP vs NTRSO Comparison

FBIOP vs NTRSO Comparison

Compare FBIOP & NTRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIOP
  • NTRSO
  • Stock Information
  • Founded
  • FBIOP N/A
  • NTRSO N/A
  • Country
  • FBIOP United States
  • NTRSO United States
  • Employees
  • FBIOP 186
  • NTRSO 23100
  • Industry
  • FBIOP Biotechnology: Pharmaceutical Preparations
  • NTRSO Major Banks
  • Sector
  • FBIOP Health Care
  • NTRSO Finance
  • Exchange
  • FBIOP Nasdaq
  • NTRSO Nasdaq
  • Market Cap
  • FBIOP N/A
  • NTRSO N/A
  • IPO Year
  • FBIOP N/A
  • NTRSO N/A
  • Fundamental
  • Price
  • FBIOP $6.37
  • NTRSO $20.28
  • Analyst Decision
  • FBIOP
  • NTRSO
  • Analyst Count
  • FBIOP 0
  • NTRSO 0
  • Target Price
  • FBIOP N/A
  • NTRSO N/A
  • AVG Volume (30 Days)
  • FBIOP N/A
  • NTRSO N/A
  • Earning Date
  • FBIOP N/A
  • NTRSO N/A
  • Dividend Yield
  • FBIOP N/A
  • NTRSO N/A
  • EPS Growth
  • FBIOP N/A
  • NTRSO N/A
  • EPS
  • FBIOP N/A
  • NTRSO N/A
  • Revenue
  • FBIOP N/A
  • NTRSO N/A
  • Revenue This Year
  • FBIOP N/A
  • NTRSO N/A
  • Revenue Next Year
  • FBIOP N/A
  • NTRSO N/A
  • P/E Ratio
  • FBIOP N/A
  • NTRSO N/A
  • Revenue Growth
  • FBIOP N/A
  • NTRSO N/A
  • 52 Week Low
  • FBIOP N/A
  • NTRSO N/A
  • 52 Week High
  • FBIOP N/A
  • NTRSO N/A
  • Technical
  • Relative Strength Index (RSI)
  • FBIOP 51.85
  • NTRSO 30.24
  • Support Level
  • FBIOP $6.40
  • NTRSO $20.24
  • Resistance Level
  • FBIOP $7.10
  • NTRSO $21.66
  • Average True Range (ATR)
  • FBIOP 0.72
  • NTRSO 0.34
  • MACD
  • FBIOP -0.01
  • NTRSO -0.08
  • Stochastic Oscillator
  • FBIOP 50.66
  • NTRSO 16.57

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

About NTRSO Northern Trust Corporation

Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of September 2024, Northern Trust had assets under custody or administration of $17.4 trillion and assets under management of $1.6 trillion.

Share on Social Networks: